Bouwinvest Real Estate Investors has invested $60m (€50m) in Blackstone’s US medical real estate investment trust BioMed Realty.

Bouwinvest, which invests internationally on behalf of Dutch pension fund BpfBouw, said it participated in Blackstone’s recapitalisation of BioMed Realty, a company which owns a US portfolio in core life science markets. 

Blackstone recently disclosed in its earnings statement that it had raised $7.5bn for its new life science office real estate perpetual vehicle.

Gijs Plantinga, Bouwinvest director North American Investments, said: “This exceptional investment opportunity meets our real value for life objectives by creating value in both financial and social terms.

“Our investment not only provides an attractive long-term return for Dutch pensioners but also helps facilitate important medical research.�

Bouwinvest, which has a target to grow its North American portfolio to $2bn by 2022, said the portfolio currently stands at $1.65bn.

“Bouwinvest sees additional long-term opportunities in affordable housing, single-family rentals and logistics in North America, as well as in alternative segments including life science office and data centres,� the Dutch investor said.

To read the digital edition of the latest Âé¶¹Ó³»­ Real Assets magazine click .